Vyntus™ ECG 12-lead PC-ECG

Vyntus™ ECG is a lightweight, compact, wearable ECG, making it the ideal 12-lead PC-based ECG for testing in pulmonary and exercise physiology laboratories. Using Bluetooth® communication from the patient back to the metabolic cart, Vyntus ECG reduces the number of cables surrounding the patient during testing.  Built into each lead wire is an impedance check that lights up when the signal is not sufficient for quality testing.

Combining Vyntus ECG  with SentrySuite™ software, users now have a single integrated database solution that makes testing, reporting, and EMR integration much easier.

Features & Benefits

  • Vyntus ECG can be used for several applications- resting ECG, stress ECG, and combined with Vyntus CPX for complete CPET
  • Small, lightweight system (220g) that fits easily on the patient and will not impede movement or comfort
  • Impedance Signal Quality Check in more than just one location – at both ECG snap connector hardware and in SentrySuite software dialog box
  • Cableless communication to software using secure Bluetooth™ technology is ideal in emergency situations if patient has to be moved from the bike or treadmill
  • When combined with Vyntus CPX, users benefit from the "Power of One": 1 user interface, 1 central database, 1 click and both ECG and gas exchange data moves simultaneously, 1 combined report, 1 EMR connection, and 1 program to train on

Please note that all products, services, or features of products and services may not be available in your local area. Please check with your local Vyaire representative.

The Latest News From Vyaire

Vyaire's Statement on the Defense Production Act to Supply Ventilator Manufacturers

“As the leading manufacturer of solutions for the treatment and monitoring of respiratory conditions at every stage of life, Vyaire Medical has been working tirelessly to deliver our ventilator equipment for patients in respiratory distress due to COVID-19, and to the healthcare workers treating

Read More
Vyaire Medical Steps Up Operations in Response to Coronavirus Pandemic

CHICAGO – April 3, 2020 – Vyaire Medical, Inc. and CEO Gaurav Agarwal today issued the following update on the company’s response to the coronavirus (COVID-19) pandemic:

Read More

Contact a Sales Representative